Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ZYME	Zymeworks Inc. Manufacturing · Year ended 2025-12-31 · USD	$105.97M	-$81.13M	-76.6%	-30.2%	38.9%	-$1.08
ZVSA	ZyVersa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$24.95M	n/a	n/a	n/a	-$4.18
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
ZOMDF	Zomedica Corp. Manufacturing · Year ended 2025-12-31 · USD	$32.03M	-$81.86M	-255.6%	-70.9%	17.4%	-$0.08
ZNTL	Zentalis Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$137.06M	n/a	-63.4%	-100.0%	-$1.91
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
YARW	Yarrow Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$570.0K	-$26.48M	n/m	-95.4%	13.8%	-$0.62
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
XLO	Xilio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$43.77M	-$35.04M	-80.1%	-99.3%	589.9%	-$4.19
XERS	Xeris Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$291.85M	$554.0K	0.2%	4.0%	43.7%	$0.00
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
XCUR	Exicure, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$4.95M	n/a	-126.0%	-100.0%	-$0.79
XBIT	XBiotech Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.54M	n/a	-32.4%	n/a	-$1.49
XBIO	Xenetic Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.98M	-$2.68M	-90.1%	-36.2%	19.0%	-$1.58
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
VTVT	vTv Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.97M	n/a	-41.9%	-100.0%	n/a
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
VTGN	Vistagen Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.27M	-$69.69M	n/m	-196.2%	161.1%	-$1.83
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
VRCA	Verrica Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.58M	-$17.89M	-50.3%	-72.3%	370.2%	-$1.68
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74
VKTX	Viking Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$359.64M	n/a	-56.3%	n/a	-$3.19
VERU	Veru Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$22.73M	n/a	-124.0%	n/a	n/a
VERA	Vera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$299.62M	n/a	-49.6%	n/a	-$4.66
VBIO	Valion Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.88M	n/a	-52.9%	n/a	n/a
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
UNCY	Unicycive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.55M	n/a	-87.9%	n/a	-$1.67
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
TVRD	Tvardi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.21M	n/a	-87.0%	n/a	-$3.26
TTRX	Turn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.19M	n/a	-68.2%	n/a	-$0.12
TRVI	Trevi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$42.76M	n/a	-23.3%	n/a	-$0.32
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
TRAW	Traws Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$9.17M	n/a	n/a	n/a	$0.82
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
TOVX	Theriva Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.74M	n/a	-154.3%	n/a	-$2.08
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
TLPH	Talphera, Inc. Manufacturing · Year ended 2025-12-31 · USD	$28.0K	-$14.29M	n/m	-83.9%	n/a	n/a
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
SYBX	Synlogic, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.00M	n/a	-8.5%	-100.0%	-$0.08
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
SVRA	Savara Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$118.84M	n/a	-58.5%	n/a	-$0.53
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
STOK	Stoke Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$184.42M	-$6.88M	-3.7%	-2.0%	404.5%	-$0.12
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
SPRB	Spruce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.97M	n/a	-91.7%	-100.0%	-$50.83
SNGX	Soligenix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.08M	n/a	-209.4%	n/a	-$2.14
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
SMNR	Semnur Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$160.42M	n/a	n/a	n/a	-$0.78
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
SLS	SELLAS Life Sciences Group, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.86M	n/a	-37.9%	n/a	-$0.25
SLN	Silence Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$559.0K	-$88.61M	n/m	-142.2%	-98.7%	-$0.63
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41
SKVI	Skinvisible, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.0K	-$1.06M	n/m	n/a	0.0%	n/a
SION	Sionna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.27M	n/a	-24.5%	n/a	-$1.88
SILO	Silo Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.1K	-$4.23M	n/m	-67.0%	0.0%	-$0.50
SIGA	Siga Technologies Inc Manufacturing · Year ended 2025-12-31 · USD	$94.57M	$23.28M	24.6%	11.7%	-31.8%	$0.32
SHPH	Shuttle Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.72M	n/a	-519.9%	n/a	-$7.16
SGMT	Sagimet Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$51.04M	n/a	-45.8%	n/a	-$1.58
SER	Serina Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$130.0K	-$19.18M	n/m	n/a	132.1%	-$1.91
SEPN	Septerna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$45.95M	-$48.88M	-106.4%	-12.8%	n/m	-$1.10
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
SCYX	Scynexis Inc Manufacturing · Year ended 2025-12-31 · USD	$20.60M	-$8.61M	-41.8%	-17.4%	449.9%	-$0.17
SCNX	Scienture Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$431.6K	-$41.51M	n/m	-59.2%	215.9%	-$2.70
SBFM	Sunshine Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.31M	-$5.98M	-16.5%	-25.9%	4.1%	n/a
RZLT	Rezolute, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$77.59M	n/a	-77.1%	n/a	-$0.75
RYTM	Rhythm Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$189.76M	-$196.54M	-103.6%	-141.3%	45.8%	-$3.11
RVRC	Revium Rx. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.45M	n/a	-195.5%	n/a	-$0.22
RVPH	Reviva Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.86M	n/a	-229.7%	n/a	n/a
RPRX	Royalty Pharma plc Manufacturing · Year ended 2025-12-31 · USD	$2.38B	$770.95M	32.4%	7.9%	5.1%	$1.78
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
RNTX	Rein Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$49.87M	n/a	-294.8%	n/a	-$1.96
RNAZ	Transcode Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.66M	n/a	-335.4%	n/a	-$52.59
RNAC	Cartesian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.80M	-$130.30M	n/m	n/a	-92.8%	-$5.02
RMTI	Rockwell Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$69.26M	-$5.31M	-7.7%	-14.4%	-31.8%	-$0.15
RLYB	Rallybio Corp Manufacturing · Year ended 2025-12-31 · USD	$858.0K	-$8.98M	n/m	-15.5%	34.9%	-$1.59
RLMD	Relmada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.39M	n/a	-66.3%	n/a	-$1.45
RKTO	Rocket One Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.47M	n/a	-202.7%	n/a	-$0.90

Rows per page: 25 50100